Clancy RL - Search Results

1

Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients.

Hazan S, Dave S, Gunaratne AW, Dolai S, Clancy RL, McCullough PA, Borody TJ. Hazan S, et al. Among authors: clancy rl. Future Microbiol. 2022 Mar;17:339-350. doi: 10.2217/fmb-2022-0014. Epub 2022 Feb 9. Future Microbiol. 2022. PMID: 35135310 Free PMC article.

2

Targeting the microbiome in Crohn's disease.

Borody TJ, Dolai S, Gunaratne AW, Clancy RL. Borody TJ, et al. Among authors: clancy rl. Expert Rev Clin Immunol. 2022 Sep;18(9):873-877. doi: 10.1080/1744666X.2022.2093186. Epub 2022 Jun 28. Expert Rev Clin Immunol. 2022. PMID: 35731859 No abstract available.

3

Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.

Borody TJ, Eslick GD, Clancy RL. Borody TJ, et al. Among authors: clancy rl. Curr Opin Pharmacol. 2019 Dec;49:43-51. doi: 10.1016/j.coph.2019.04.017. Epub 2019 Jun 5. Curr Opin Pharmacol. 2019. PMID: 31173991 Review.

4

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

Borody TJ, Pang G, Wettstein AR, Clancy R, Herdman K, Surace R, Llorente R, Ng C. Borody TJ, et al. Aliment Pharmacol Ther. 2006 Feb 15;23(4):481-8. doi: 10.1111/j.1365-2036.2006.02793.x. Aliment Pharmacol Ther. 2006. PMID: 16441468 Free article.

5

Probiotics under the regulatory microscope.

Henriksson A, Borody T, Clancy R. Henriksson A, et al. Expert Opin Drug Saf. 2005 Nov;4(6):1135-43. doi: 10.1517/14740338.4.6.1135. Expert Opin Drug Saf. 2005. PMID: 16255670 Review.

6

Can the response to eradication therapy in Helicobacter pylori infection be predicted?

Clancy R, Borody T, Ren Z, Pang G. Clancy R, et al. Can J Gastroenterol. 2003 Jun;17 Suppl B:58B-61B. doi: 10.1155/2003/585862. Can J Gastroenterol. 2003. PMID: 12845354 Review.

7

High prevalence of Crohn disease and ulcerative colitis among older people in Sydney.

Pudipeddi A, Liu J, Kariyawasam V, Borody TJ, Cowlishaw JL, McDonald C, Katelaris P, Chapman G, Corte C, Lemberg DA, Lee CH, Keshava A, Napoli J, Clancy R, Chan W, Paramsothy S, Leong R. Pudipeddi A, et al. Med J Aust. 2021 May;214(8):365-370. doi: 10.5694/mja2.50910. Epub 2021 Jan 27. Med J Aust. 2021. PMID: 33502004

8

Shift of the gastric T-cell response in gastric carcinoma.

Ren Z, Pang G, Clancy R, Li LC, Lee CS, Batey R, Borody T, Dunkley M. Ren Z, et al. J Gastroenterol Hepatol. 2001 Feb;16(2):142-8. doi: 10.1046/j.1440-1746.2001.02385.x. J Gastroenterol Hepatol. 2001. PMID: 11207893

9

Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations.

Ren Z, Borody T, Pang G, Dunkley M, Clancy R, Xia HH, Chu KM, Wong J, Wong BC. Ren Z, et al. Aliment Pharmacol Ther. 2005 Jan 1;21(1):83-9. doi: 10.1111/j.1365-2036.2004.02293.x. Aliment Pharmacol Ther. 2005. PMID: 15644049 Free article.

10

Circulating T-cell response to Helicobacter pylori infection in chronic gastritis.

Ren Z, Pang G, Lee R, Batey R, Dunkley M, Borody T, Clancy R. Ren Z, et al. Helicobacter. 2000 Sep;5(3):135-41. doi: 10.1046/j.1523-5378.2000.00021.x. Helicobacter. 2000. PMID: 10971677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page